Discovery Life Sciences

We are the biospecimen and biomarker specialists™. Biospecimen solutions and expert service laboratories to accelerate precision medicine programs.

[Discovery Life Sciences @DiscLS]

This AANHPI Heritage Month, we celebrate the contributions, perspectives, & impact of Asian American, Native Hawaiian, & Pacific Islander communities across science, healthcare, & beyond. Thank you to those who drive science & innovation forward every day.

#AANHPI

[Discovery Life Sciences @DiscLS]

4,812,000 Cancer deaths have been averted since 1991*.

This National Cancer Research Month, we recognize the researchers and clinicians advancing oncology and the progress shaping earlier detection, better treatments, and prevention.

*American Cancer Society, 2025

[Discovery Life Sciences @DiscLS]

World DNA Day is more than a milestone. It reflects a global community turning generic insight into real-world impact. Each sequence moves us forward. Efforts like SpecimenSeq help strengthen the data foundations, driving progress in personalized medicine. https://t.co/wl6nLmCXCM

[Discovery Life Sciences @DiscLS]

Our Newtown lab’s My Green Lab® Certification was a '25 highlight! In 2026 the team has re-enrolled in the Freezer Challenge, launched a Green ACTION Calendar, & will soon get a Green Snack Vending Machine with healthier options. #EarthDay https://t.co/Qbn5keTK1B

[Discovery Life Sciences @DiscLS]

Our latest blog breaks down what’s driving this shift and what it means for development teams navigating an increasingly compressed timeline.

Read the full analysis to see what has changed and what comes next. https://t.co/6ttJJcaE4J

[Discovery Life Sciences @DiscLS]

1st ever use of CAR-T in a neurodegenerative setting. CD4+ CAR-T cells targeting amyloid-beta plaques and improved brain health in Alzheimer’s mouse models. If this translates to humans, it opens a new frontier for cell-based immunotherapies. https://t.co/84sqRsGC2N

[Discovery Life Sciences @DiscLS]

New Nature paper demonstrates proof of concept for in vivo CAR-T using dual delivery of CRISPR-Cas9 and CAR to improve precise delivery and reduce off-target risk. Early days, but a big step toward lower-cost, more accessible cell therapies. https://t.co/xg3vity9IX

[Discovery Life Sciences @DiscLS]

Recent FDA rare disease wins are moving the needle for patients. Denali’s Avlayah for Hunter syndrome was supported by surrogate biomarker reduction in CSF heparan sulfate, & Rocket Pharma’s  Kresladi  for LAD‑1 is the 1st CGT approval of '26.
https://t.co/yUQLt6cWZy

[Discovery Life Sciences @DiscLS]

What’s next in oncology research?

Discovery is presenting it at #AACR2026 in San Diego!

From ADC evaluation to proteogenomics and tumor immunology, join our poster session April 19 & 22 to see the latest data.

More details: https://t.co/l22qwRiYU1

[Discovery Life Sciences @DiscLS]

Deep proteomic insight starts with the right enrichment strategy.

Dr. Jessica Moore explains how the SEER Proteograph workflow enables broad protein discovery from complex biofluids, powering biomarkers and deep LC-MS analysis.

https://t.co/m2ZKoAmDeJ

[Discovery Life Sciences @DiscLS]

Legacy biospecimens hold decades of insight but are often underused. The Discovery Legacy Program gives researchers access to high‑quality legacy specimens for studying disease progression, treatment response, and long‑term outcomes.

Read our latest blog: https://t.co/9aEmKeZhbJ

[Discovery Life Sciences @DiscLS]

Discovery Life Sciences + Mindpeak brings AI-powered precision to pathology by enhancing consistency, reducing risk, & strengthening confidence in biomarker driven decisions.

Read the press release: https://t.co/FU1xZ13OzC

[Discovery Life Sciences @DiscLS]

Automation is key to scalable and reproducible proteomics.

In the latest video in our series, Dr. Jessica Moore explains how the SEER Proteograph and Agilent AssayMAP Bravo enable scalable sample prep and deeper proteome coverage for large, complex studies.

[Discovery Life Sciences @DiscLS]

March marks #WomensHistoryMonth! From human resources and accounting to quality assurance and pathology, women play a vital role in our science community. Swipe to see how Discovery’s very own Annette Mühleisen and Mandy Andrade contribute to pushing the world of science forward!

[Discovery Life Sciences @DiscLS]

Oncology biospecimens + precision biomarker services — under one roof.

See us at #AACR26, booth #3038 → San Diego, April 17–22 Book time with our team: https://t.co/l22qwRjwJz

[Discovery Life Sciences @DiscLS]

How do IVDR regulations impact clinical trial assay development?

Join Discovery's Scott Reid, VP & Global Head of Companion Diagnostic Services during his presentation at World CB & CDx Summit EU on Tuesday, 31 March at 5:20

Connect with our experts: https://t.co/BIE2IM9pNP

[Discovery Life Sciences @DiscLS]

March marks #WomensHistoryMonth! From human resources and accounting to quality assurance and pathology, women play a vital role in our science community. Swipe to see how Discovery’s very own Tamara Bowles and Mimi Lo contribute to pushing the world of science forward!

[Discovery Life Sciences @DiscLS]

Autoimmune research doesn’t follow a standard playbook.

Read how Discovery supports autoimmune research.

https://t.co/8OvvavJzC4

[Discovery Life Sciences @DiscLS]

Limited seats. Limitless impact.

Join Discovery on the B4 Tour, an in-person 3-city series exploring innovations in genomics, proteomics, molecular pathology, & cell biology powering precision medicine.

Register today.
https://t.co/yzQMKB4Ryh

[Discovery Life Sciences @DiscLS]

New app note: 3D hepatocyte spheroids deliver longer-lived, human-relevant metabolism for low-clearance drug compounds.

Explore our workflow + performance data: https://t.co/hWYDzl9bKL